Scientists and the Food and Drug Administration (FDA) are discussing how new technologies in ophthalmology, which make it possible to collect better data about experimental treatments, might affect FDA clinical trials requirements.

Two transporters that deliver alternative energy sources to the eye may help delay retinal damage that can occur in diabetes, researchers say.

Mutant mice could provide genetic clues to understanding incurable human sight loss resulting from retinal degeneration. Research published in the online open access journal Genome Biology uncovers a role for microRNA in retinal disease, and may point the way to future therapies.

All vision, including reading this sentence, depends on a constant series of infinitesimal jumps by the eyeball that centers the retina on target objects—words or phrases in the case of reading.

Scientists at Schepens Eye Research Institute, an affiliate of Harvard Medical School, have discovered a simple and inexpensive way for patients with retinal and other eye disease to keep track of changes in their vision loss.

Homocysteine, an amino acid believed to contribute to heart attack, stroke and dementia, likely also is a player in retinal damage and vision loss, researchers say.

Researchers at the University of Southern California (USC) are developing a tiny camera for prosthetic systems that can be implanted directly into the human eye and connected to the retina, the part of the eye that converts visual information into electric signals that travel to the brain.

People suffering from a severe retinal disease will sooner or later lose their eyesight considerably or even become completely blind. Those affected, family members, researchers and doctors hope that this fate might be avoided one day by a better understanding of the reasons for this disease.

A special type of cell found in the eye has been found to be very important in regenerating the retina in zebrafish and restoring vision even after extensive damage. Now, a UK team of scientists believe they may be able to use these cells – known as Müller glial cells – to regenerate damaged retina in humans, according to a study published this month in the journal Stem Cells.

Michael Marmor, MD, wanted to know what it was like to see through the eyes of an artist. Literally. After writing two books on the topic of artists and eye disease, the Stanford University School of Medicine ophthalmologist decided to go one step further and create images that would show how artists with eye disease actually saw their world and their canvases.